|
|
Programs and Activities
-
Patient Labeling and Risk
Communication.
-
Medication Guides
-
Drug Safety and Risk Management (DSaRM)
Advisory Committee gained full committee status on June 1, 2002.
-
MedWatch MedWatch, the FDA Safety
Information and Adverse Event Reporting Program, provides safety information for all
FDA-regulated medical products (drugs, biologics, medical devices, and dietary supplements) to
both healthcare professionals and the general public.
- MedWatch Partners work with FDA to
help keep their members informed about medical product safety information
|
|
|